Evidence map›Paper›PMID 38455514›Full record

ArticleThe journal of cardiovascular aging2024

Hypoxia-induced stabilization of HIF2A promotes cardiomyocyte proliferation by attenuating DNA damage.

Shah R Ali, Ngoc Uyen Nhi Nguyen, Ivan Menendez-Montes, Ching-Cheng Hsu, Waleed Elhelaly, Nicholas T Lam, Shujuan Li, Abdallah Elnwasany, Yuji Nakada, Suwannee Thet and 2 more

Open access · hybridAbstract read
In one paragraph

Article in The journal of cardiovascular aging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 4 countries.

Shah R AliDepartment of Medicine, Division of Cardiology, Columbia University Irving Medical Center, New York, NY 10032, USA.ORCID 0000-0002-1241-6826
Ngoc Uyen Nhi NguyenDepartment of Internal Medicine, Division of Cardiology, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Ivan Menendez-MontesDepartment of Internal Medicine, Division of Cardiology, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.ORCID 0000-0001-5252-9502
Ching-Cheng HsuDepartment of Internal Medicine, Division of Cardiology, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Waleed ElhelalyDepartment of Internal Medicine, Division of Cardiology, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.ORCID 0000-0002-6942-3680
Nicholas T LamDepartment of Internal Medicine, Division of Cardiology, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Shujuan LiDepartment of Pediatric Cardiology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, Guangdong, China.
Abdallah ElnwasanyDepartment of Internal Medicine, Division of Cardiology, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Yuji NakadaDepartment of Biomedical Engineering, University of Alabama at Birmingham, Birmingham, AL 35249, USA.
Suwannee ThetDepartment of Internal Medicine, Division of Cardiology, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Roger S Y FooCardiovascular Research Institute, National University of Singapore, and Genome Institute of Singapore, Singapore 119228, Singapore.
Hesham A SadekDepartment of Internal Medicine, Division of Cardiology, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
The University of Texas Southwestern Medical Center · USColumbia University Irving Medical Center · USGenome Institute of Singapore · SGSpanish National Centre for Cardiovascular Research · ESSun Yat-sen University · CNUniversity of Alabama at Birmingham · US

Funding

Project 3 - Role of Proline Metabolism in Regulation of Mammalian Cardiomyocyte ProliferationP01HL160476 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Jianyi Zhang · 2022 to 2026
$13.1M
T-Cell-Mediated Inflammatory Response in Neonatal Heart RegenerationP01HL160488 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI Hesham Sadek · 2023 to 2026
$10.2M
Induction of Cardiomyocyte Proliferation via Transient Expression of Cell Cycle Factors as a Promising Therapy for Heart FailureR01HL147921 · NHLBI · UNIVERSITY OF LOUISVILLE · PI Tamer M A Mohamed, Jonathan Satin · 2020 to 2026
$5.3M
Training in Cardiovascular ResearchT32HL125247 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI JOSEPH A HILL · 2015 to 2026
$4.3M
Supply and Demand: Oxygen and Workload Regulate Cardiomyocyte ProliferationR35HL166563 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI Hesham Sadek · 2023 to 2026
$4.1M
Deciphering the Neonatal Cardiac Regenerative Potential and Regulators in Large AnimalsR01HL149137 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SADEK, HESHAM, ZANGI, LIOR · 2019 to 2022
$2.5M
Calcineurin Regulates Cardiomyocyte Cell Cycle Through Meis1 and Hoxb13R01HL147276 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI SADEK, HESHAM · 2019 to 2022
$1.6M
Role of IGFBP3 in Neonatal Heart RegenerationK08HL153788 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI ALI, SHAH RUKH · 2021 to 2025
$751k
NHLBI NIH HHS K08 HL153788NHLBI NIH HHS P01 HL160476NHLBI NIH HHS P01 HL160488NHLBI NIH HHS R01 HL147276NHLBI NIH HHS R01 HL147921NHLBI NIH HHS R01 HL149137NHLBI NIH HHS R35 HL166563NHLBI NIH HHS T32 HL125247
6 · The paper itself

Abstract

Introduction: Gradual exposure to a chronic hypoxic environment leads to cardiomyocyte proliferation and improved cardiac function in mouse models through a reduction in oxidative DNA damage. However, the upstream transcriptional events that link chronic hypoxia to DNA damage have remained obscure. Aim: We sought to determine whether hypoxia signaling mediated by the hypoxia-inducible factor 1 or 2 (HIF1A or HIF2A) underlies the proliferation phenotype that is induced by chronic hypoxia. Methods and Results: We used genetic loss-of-function models using cardiomyocyte-specific HIF1A and HIF2A gene deletions in chronic hypoxia. We additionally characterized a cardiomyocyte-specific HIF2A overexpression mouse model in normoxia during aging and upon injury. We performed transcriptional profiling with RNA-sequencing on cardiac tissue, from which we verified candidates at the protein level. We find that HIF2A - rather than HIF1A - mediates hypoxia-induced cardiomyocyte proliferation. Ectopic, oxygen-insensitive HIF2A expression in cardiomyocytes reveals the cell-autonomous role of HIF2A in cardiomyocyte proliferation. HIF2A overexpression in cardiomyocytes elicits cardiac regeneration and improvement in systolic function after myocardial infarction in adult mice. RNA-sequencing reveals that ectopic HIF2A expression attenuates DNA damage pathways, which was confirmed with immunoblot and immunofluorescence. Conclusion: Our study provides mechanistic insights about a new approach to induce cardiomyocyte renewal and mitigate cardiac injury in the adult mammalian heart. In light of evidence that DNA damage accrues in cardiomyocytes with aging, these findings may help to usher in a new therapeutic approach to overcome such age-related changes and achieve regeneration.

Indexed as

cell divisionDNA damageHIF2AHypoxiamyocardial infarctionregeneration

Identifiers

PMID38455514
PMCPMC10919901
OpenAlexW4391329818

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.